2018
DOI: 10.1186/s12914-018-0140-z
|View full text |Cite
|
Sign up to set email alerts
|

Realising the right to sexual and reproductive health: access to essential medicines for medical abortion as a core obligation

Abstract: BackgroundWHO has a pivotal role to play as the leading international agency promoting good practices in health and human rights. In 2005, mifepristone and misoprostol were added to WHO’s Model List of Essential Medicines for combined use to terminate unwanted pregnancies. However, these drugs were considered ‘complementary’ and qualified for use when in line with national legislation and where ‘culturally acceptable’.DiscussionThis article argues that these qualifications, while perhaps appropriate at the tim… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 20 publications
0
7
0
Order By: Relevance
“…No constitution obliges the State to respect the provision of essential medicines (i.e. Respecting essential medicines could entail the government not interfering with access to specific classes of medicines such as contraception or for medical abortion) [ 54 ]. Full results are reported elsewhere [ 37 ].…”
Section: Resultsmentioning
confidence: 99%
“…No constitution obliges the State to respect the provision of essential medicines (i.e. Respecting essential medicines could entail the government not interfering with access to specific classes of medicines such as contraception or for medical abortion) [ 54 ]. Full results are reported elsewhere [ 37 ].…”
Section: Resultsmentioning
confidence: 99%
“…Combining medication uterine evacuation with manual vacuum aspiration within the same curriculum appeared feasible and indeed complementary as misoprostol and mifepristone are increasingly available in countries affected by fragility or crises [ 32 , 33 ]. Additionally, universal access to such medications, which are part of the WHO Model List of Essential Medicines [ 34 ], adhere to contemporary standards on sexual and reproductive health and rights [ 35 ].…”
Section: Discussionmentioning
confidence: 99%
“…The high frequency of curettage in Latin America had been found in a study of medication provision through telemedicine in the entire world 59 . It is also worth encouraging a reflection regarding the inclusion of mifepristone in the list of medications available in Brazil, considering the greater efficacy and safety of the combined use of this medication with misoprostol in the initial phase of inducing abortions 60 .…”
Section: Discussionmentioning
confidence: 99%